Fact CheckerSign in

NCT06955962Enrolling by invitation

Examining the Effect of Mandala Art Therapy on Symptoms and Quality of Life in Multiple Sclerosis Patients

Source: ClinicalTrials.gov · Last updated 9 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a randomized controlled, pre-test-post-test experimental research aimed at examining the effects of mandala art therapy on symptom severity and quality of life in individuals diagnosed with Multiple Sclerosis (MS). The main goal is to determine whether mandala art therapy helps reduce the frequency and severity of MS symptoms while improving participants' overall quality of life. It is expected that mandala art therapy will support MS patients in managing current and potential symptoms, coping more effectively with the disease, and improving adherence to treatment. As a result, a reduction in healthcare utilization, related costs, MS-related complications, and mortality is anticipated. The study will be conducted between May and August 2025 at the Neurology Outpatient Clinic of Karadeniz Technical University Practice and Research Center, involving 70 patients-35 in the intervention group receiving mandala art therapy and 35 in the control group receiving standard care.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
70 (estimated)
First submitted
11 Apr 2025
Start date
10 May 2025
Primary completion date
10 Jul 2025
Lead sponsor
Karadeniz Technical University
NCT number
NCT06955962

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 10 May 2025 to the primary completion date, 10 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those receiving inpatient treatment for MS
  • Individuals currently engaged in any form of active art therapy

Other illness

  • Individuals with a diagnosed psychiatric disorder
  • Individuals with allergies to materials used in the mandala therapy sessions

Age

  • Individuals aged 18 years or younger

Other

  • Those who have experienced an MS relapse within the past three months
  • Those with a physical disability that prevents them from participating in the mandala activity
  • Those with communication or perception impairments
  • Those who cannot be reached via phone and/or text message

Who the study is looking for

  • Residing in the city center of Trabzon
  • Diagnosed with Multiple Sclerosis at least six months prior
  • Have not experienced an MS relapse within the past three months
  • Receiving outpatient treatment for MS
  • Literate
  • Have no prior experience with mandala practice
  • Not currently participating in any form of art therapy
  • Have no communication or perception impairments

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karadeniz Technical University
Coordinator of this site? Confirm its status
TrabzonTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.